Nucleoside-lipid-based nanoparticles for cisplatin delivery

ACS Nano

Volumn 5, Issue 11, 2011, Pages 8649-8655

  Khiati, Salim ^a,b   Luvino, Delphine ^c   Oumzil, Khalid ^a,b   Chauffert, Bruno ^d   Camplo, Michel ^c   Barthélémy, Philippe ^a,b  

^a INSERM U869   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c AIX MARSEILLE UNIVERSITÉ   (France)

^d AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

cancer; cisplatin; drug delivery; nanoparticles; nucleoside lipids

Indexed keywords

ANTI-CANCER AGENTS; CANCER; CANCER CELL LINES; CIS-PLATIN; DELIVERY VEHICLE; DRUG DELIVERY SYSTEM; NUCLEOSIDE-LIPIDS; POLAR HEAD;

BIOMOLECULES; CELL CULTURE; DISEASES; DRUG DELIVERY; LIPIDS; PLATINUM COMPOUNDS;

NANOPARTICLES;

ANTINEOPLASTIC AGENT; CISPLATIN; DRUG CARRIER; LIPID; NANOPARTICLE; NUCLEOSIDE;

ARTICLE; CHEMISTRY; HUMAN; METABOLISM; NANOTECHNOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; DRUG CARRIERS; HUMANS; LIPIDS; NANOPARTICLES; NANOTECHNOLOGY; NUCLEOSIDES;

EID: 81855226447     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn202291k     Document Type: Article

References (32)

1. Rosenberg, B.; VanCamp, L.; Trosko, J. E.; Mansour, V. H. Platinum Compounds: A New Class of Potent Antitumour Agents Nature 1969, 222, 385-386
2. Jamieson, E. R.; Lippard, S. J. Structure, Recognition, and Processing of Cisplatin-DNA Adducts Chem. Rev. 1999, 99, 2467-2498
3. Galanski, M.; Jakupec, M. A.; Keppler, B. K. Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches Curr. Med. Chem. 2005, 12, 2075-2094 (Pubitemid 41093559)
4. Stordal, B.; Davey, M. Understanding Cisplatin Resistance Using Cellular Models IUBMB Life 2007, 59, 696-699 (Pubitemid 350035586)
5. Yao, X.; Panichpisal, K.; Kurtzman, N.; Nugent, K. Cisplatin Nephrotoxicity: A Review Am. J. Med. Sci. 2007, 334, 115-124 (Pubitemid 47262919)
6. Van den Bent, M. J.; van Putten, W. L. J.; Hilkens, P. H. E.; de Wit, R.; Van der Burg, M. E. L. Retreatment with Dose-Dense Weekly Cisplatin after Previous Cisplatin Chemotherapy Is Not Complicated by Significant Neuro-toxicity Eur. J. Cancer 2002, 38, 387-391 (Pubitemid 34121966)
7. Duncan, R. Polymer Conjugates as Anticancer Nanomedicines Nat. Rev. Cancer 2006, 6, 688-701 (Pubitemid 44286001)
8. Wagner, V.; Dullaart, A.; Bock, A. K.; Zweck, A. The Emerging Nanomedicine Landscape Nat. Biotechnol. 2006, 24, 1211-1217 (Pubitemid 44564760)
9. Ferrari, M. Cancer Nanotechnology: Opportunities and Challenges Nat. Rev. Cancer 2005, 5, 161-171 (Pubitemid 40314948)
10. Brigger, I.; Dubernet, C.; Couvreur, P. Nanoparticles in Cancer Therapy and Diagnosis Adv. Drug Delivery Rev. 2002, 54, 631-651 (Pubitemid 35247520)
11. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy Nat. Nanotechnol. 2007, 2, 751-760 (Pubitemid 350223348)
12. Boulikas, T. Low Toxicity and Anticancer Activity of a Novel Liposomal Cisplatin (Lipoplatin) in Mouse Xenografts Oncol. Rep. 2004, 12, 3-12
13. Burger, K. N. J.; Staffhorst, R. W. H. M.; de Vijlder, H. C.; Velinova, M. J.; Bomans, P. H.; Frederik, P. M.; de Kruijff, B. Nanocapsules: Lipid-Coated Aggregates of Cisplatin with High Cytotoxicity Nat. Med. 2002, 8, 81-84 (Pubitemid 34101733)
14. Uchino, H.; Matsumura, Y.; Negjshj, T.; Koizumi, F.; Hayashi, T.; Honda, T.; Nishivama, N.; Kataoka, K.; Naito, S.; Kakizoe, T. Cisplatin-Incorporating Polymeric Micelles (NC-6004) Can Reduce Nephrotoxicity and Neurotoxicity of Cisplatin in Rats Br. J. Cancer 2005, 93, 678-687 (Pubitemid 41486459)
15. Santosh, A.; Che-Ming, J. H.; Liangfang, Z. Polymer-Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug Delivery ACS Nano 2010, 4, 251-258
16. Tian, Y.; Bromberg, L.; Lin, S. N.; Alan Hatton, T.; Tam, K. C. Complexation and Release of Doxorubicin from Its Complexes with Pluronic P85- b -Poly(acrylic acid) Block Copolymers J. Controlled Release 2007, 121, 137-145 (Pubitemid 47212535)
17. Kaida, S.; Cabral, H.; Kumagai, M.; Kishimura, A.; Terada, Y.; Sekino, M.; Aoki, I.; Nishiyama, N.; Tani, T.; Kataoka, K. Visible Drug Delivery by Supramolecular Nanocarriers Directing to Single-Platformed Diagnosis and Therapy of Pancreatic Tumor Model Cancer Res. 2010, 70, 7031-7041
18. Boulikas, T.; Vougiouka, M. Recent Clinical Trials Using Cisplatin, Carboplatin and Their Combination Chemotherapy Drugs (Review) Oncol. Rep. 2004, 11, 559-595
19. Dhar, S.; Gu, F. X.; Langer, R.; Farokhzad, O. C.; Lippard, S. J. Targeted Delivery of Cisplatin to Prostate Cancer Cells by Aptamer Functionalized Pt(IV) Prodrug-PLGA-PEG Nanoparticles Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 17356-17361
20. Dhar, S.; Kolishetti, N.; Lippard, S. J.; Farokhzad, O. C. Targeted Delivery of a Cisplatin Prodrug for Safer and More Effective Prostate Cancer Therapy in Vivo Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 1850-1855
21. Paraskar, A. S.; Soni, S.; Chin, K. T.; Chaudhuri, P.; Muto, K. W.; Berkowitz, J.; Handlogten, M. W.; Alves, N. J.; Bilgicer, B.; Dinulescu, D. M. et al. Harnessing Structure-Activity Relationship To Engineer a Cisplatin Nanoparticle for Enhanced Antitumor Efficacy Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 12435-12440
22. Gissot, A.; Camplo, M.; Grinstaff, M. W.; Barthélémy, P. Nucleoside, Nucleotide and Oligonucleotide Based Amphiphiles: A Successful Marriage of Nucleic Acids with Lipids Org. Biomol. Chem. 2008, 6, 1324-1333 (Pubitemid 351469849)
23. Barthélémy, P. Nucleoside-Based Lipids at Work: From Supramolecular Assemblies to Biological Applications CR Chimie 2009, 12, 171-179
24. Khiati, S.; Pierre, N.; Andriamanarivo, S.; Grinstaff, M. W.; Arazam, N.; Nallet, F.; Navailles, L.; Barthélémy, P. Anionic Nucleotide-Lipids for In Vitro DNA Transfection Bioconjugate Chem. 2009, 20, 1765-1772
25. Chabaud, P.; Camplo, M.; Payet, D.; Serin, G.; Moreau, L.; Barthélémy, P.; Grinstaff, M. W. Cationic Nucleoside Lipids for Gene Delivery Bioconjugate Chem. 2006, 17, 466-472
26. Burger, K. N.; Staffhorst, R. W.; De Vijlder, H. C.; Velinova, M. J.; Bomans, P. H.; Frederik, P. M.; Kruijff, B. Nanocapsules: Lipid-Coated Aggregates of Cisplatin with High Cytotoxicity Nat. Med. 2002, 8, 81-84 (Pubitemid 34101733)
27. Legendre, F.; Véronique Bas, V.; Kozelka, J.; Chottard, J. C. A Complete Kinetic Study of GG versus AG Platination Suggests that the Doubly Aquated Derivatives of Cisplatin Are the Actual DNA Binding Species Chem.-Eur. J. 2000, 6, 2002-2010
28. Chupin, V.; de Kroon, A. I.; de Kruijff, B. Molecular Architecture of Nanocapsules, Bilayer-Enclosed Solid Particles of Cisplatin J. Am. Chem. Soc. 2004, 42, 13816-13821 (Pubitemid 39407260)
29. Zwelling, L. A.; Kohn, K. W.; Ross, W. E.; Ewig, R. A.; Anderson, T. Kinetics of Formation and Disappearance of a DNA Cross-Linking Effect in Mouse Leukemia L1210 Cells Treated with cis and trans -Diamminedichloroplatinum(II) Cancer Res. 1978, 38, 1762-1768 (Pubitemid 8349726)
30. Kelland, L. The Resurgence of Platinum-Based Cancer Chemotherapy Nat. Rev. Cancer 2007, 7, 573-584 (Pubitemid 47106628)
31. Kartalou, M.; Essigmann, J. M. Mechanisms of Resistance to Cisplatin Mutat. Res. 2001, 478, 23-43 (Pubitemid 32530848)
32. Siddik, Z. H. Cisplatin: Mode of Cytotoxic Action and Molecular Basis of Resistance Oncogene 2003, 22, 7265-7279 (Pubitemid 37487159)